Oaknet Healthcare Pvt. Ltd. is an Indian pharmaceutical company with its headquarters in Mumbai, Maharashtra, India. The company was founded by R. S. Raghav along with a group of professionals in the year 2015. It was incorporated on the 8th of August in the year 2011. Raghav has been a part of the Indian pharmaceutical market for a long time and has a rich experience. He has previously worked with several reputed companies, including the Mumbai-based pharmaceutical company Lupin Limited. Oaknet Healthcare is mainly focused on non-communicable diseases and is a wholly owned subsidiary of the Indian pharmaceutical company called Eris Lifesciences Ltd. which was founded by Amit Bakshi in the year 2007 and is headquartered in Ahmedabad. Oaknet Healthcare is also known by the name Eris Oaknet Healthcare Pvt. Ltd. The parent company Eris has a presence in the areas of pain management, nutritionals, anti-diabetics, anti-infectives, cardiovascular disorders, orthopedics, respiratory disorders, pediatrics, neuroscience and gastrointestinal diseases. It entered into the areas of dermatology, cosmetology and gynecology with this acquisition. Eris Oaknet Healthcare Pvt. Ltd. made an acquisition of the Indian Operations of Adcock Ingram Healthcare, which is a South African multinational pharmaceutical company, in the year 2016. Post this acquisition, the resultant company was called Eris Oaknet Healthcare Pvt Ltd. The company has also made acquisitions of seven Sandoz brands from the company Novartis which is originally based in Switzerland.

The company specializes in the therapy areas of dermatology, cosmetology, cardiovascular diseases, diabetology, orthopedics, women’s health, pain Management and nutritionals. Oaknet Healthcare also has a skincare range which includes lotions, sunscreens and others.

Oaknet Healthcare Pvt. Ltd. operates in collaboration with its manufacturing partners and also has thirteen loan licensing production facilities. All the manufacturing units operate according to international standards and have received approval from major international regulatory bodies.The company has its markets throughout the country as well as outside it. The company has a global presence in Sri Lanka, Myanmar, Cambodia, Kenya, Mauritius, Jamaica, Africa, Middle East and South and Central America.

Some of the top products of the company are COSVATE-GM, COSMELITE, FLUCOS, COSVATE-G, COSLYTE, JECTOCOS PLUS, PRUGO, MENABOL, COSKLOT, FEROSE, AMROLSTAR, FORISTAL, CURAM, COSKLOT PLUS, METOPAR, LULILOK, COSMELITE NEXT, FLUCOS ITZ, COSVATE, EFATOP-PE, JECTOCOS-LIPO, REGLAN, HIRUDAL, JECTOCOS, FEROSE XT, COSGLO, FUTOP-B, CERATOP, GRETACAL, ACERON-TC, FONDASTAR, ACERON MR, COSKLOT-MF, APIMORE, L-CETRON, SUPRAGLIP-M, GLORIMET VG, COSVATE-S, EXEPTION, COSVATE SOR, ZORAY, GLORISTAT, FEMIKIRO, GLORIMET G, VIBROX, SUPRANERV, PERNEX AC, FUTOP, MOMTAS and DENSICAL-XT.